AMI BIOTECH PVT. LTD.

ami-biotech-pvt-ltd-logo

Ami biotech is leading premier nutraceuticals manufacturers, supplier, and exporter.

#SimilarOrganizations #People #Website #More

AMI BIOTECH PVT. LTD.

Social Links:

Industry:
Dietary Supplements Manufacturing Nutraceutical

Founded:
2015-12-01

Address:
Vadodara, Gujarat, India

Country:
India

Website Url:
http://www.amibiotech.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Amazon Facebook Sharer NameBright CaptainForm


Similar Organizations

amorphical-logo

Amorphical

Amorphical is a pharmaceutical company that manufactures a unique form of calcium.

scitech-specialities-logo

SciTech Specialities

SciTech Specialities is a pharmaceutical company that manufactures effervescent granules and tablets using aqueous granulation technology.

vesta-nutra-logo

Vesta Nutra

Vesta Nutra operates in the manufacturing business of nutraceuticals, dietary supplements and nutritional ingredients.

Current Employees Featured

not_available_image

Girish Chovatia
Girish Chovatia Founder & CEO @ Ami Biotech Pvt. Ltd.
Founder & CEO

Founder


not_available_image

Girish Chovatia

Official Site Inspections

http://www.amibiotech.com

  • Host name: ec2-13-223-25-84.compute-1.amazonaws.com
  • IP address: 13.223.25.84
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Ami Biotech Pvt. Ltd."

AIM Biotech - Crunchbase Company Profile & Funding

AIM Biotech offers a modular platform to co-culture multiple cell types in discrete 3D and 2D channels.See details»

AIM Biotech 2025 Company Profile: Valuation, Funding โ€ฆ

Information on valuation, funding, cap tables, investors, and executives for AIM Biotech. Use the PitchBook Platform to explore the full profile.See details»

Technology - AIM Biotech

Multicellular culture made possible, with meaningful organization into models of biological systems. ... email: [email protected]. address: 21 Biopolis Road #01-24 Nucleos โ€ฆSee details»

AIM Biotech - LinkedIn

AIM Biotech's platform and world-class lab services let drug researchers get more relevant, human-focused data at every stage of development. That means more informed decisions and less wasted time.See details»

AIM Biotech - 2025 Company Profile - Tracxn

Apr 23, 2025 Some key features of AIM microfluidic chips are - Long working regions that are easily injectable with hydrogel, with low risk of leakage; Gas permeable bottom laminate โ€ฆSee details»

AIM Biotech โ€“ Journey of an early-stage VC funded โ€ฆ

Aug 20, 2021 By Brendan Sieow and Su Chengxun. AIM Biotech is a Singapore-based biotech start-up that builds 3D cell culture systems, which can mimic human organs and disease models for drug discovery and testing by โ€ฆSee details»

Reportable

Oct 15, 2021 [email protected]. Social Accounts Twitter. LinkedIn. Facebook. News Releases MatTek and AIM Biotech Partner on Advanced 3D Tissue Culture Organ-on-a-Chip Systems. Boston, MA - June 1, 2023 โ€“ โ€ฆSee details»

AIM Biotech - The 3Rs Collaborative

AIM Biotech is a leading bioengineering company, offering scalable, cost-effective 3D cell culture platforms, drug screening services, and customized assay development. By combining model โ€ฆSee details»

AIM Biotech - AIM Completes Series A to Accelerate Growth of its โ€ฆ

Jim McGorryโ€™s guiding focus after over three decades in the life-sciences industry: โ€œMake a difference in the lives of patients.โ€ McGorry is a career executive in the biotech industry, โ€ฆSee details»

Aim Biotech - Overview, News & Similar companies - ZoomInfo

Nov 16, 2021 Who is Aim Biotech. AIM Biotech's 3D human biology-on-a-chip technology empowers biotechnology and pharmaceutical companies to revolutionize their preclinical drug โ€ฆSee details»

How AIM Biotech is automating organ-on-a-chip drug โ€ฆ

When the scientists at AIM Biotech developed our idenTx organ-on-a-chip (OOAC) platform for human cell-based drug discovery, we focused on creating a system that could be used by anyone implementing OOAC-based tissue โ€ฆSee details»

AIM Biotech - Neuroscience 2023

Sep 6, 2023 https://aimbiotech.com Categories (8) Cell Culture, Contract Research Organization, Drug Discovery, Imaging Systems, In Vivo and In Vitro Testings, Laboratory โ€ฆSee details»

AIM Biotech Launches Organ-on-a-Chip Contract Research Service

March 2, 2021 โ€” Singapore & Boston, MA โ€” AIM Biotech has launched a contract research service, which uses its organ-on-a-chip technology to accelerate and improve drug discovery โ€ฆSee details»

3D IN VITRO MODEL OF THE BLOOD-BRAIN BARRIER

The organization of the all-human cells i.e., human primary endothelial cells (EC), brain pericytes (PC) and astrocytes (AC) into ... www.aimbiotech.com [email protected]. AIM 3D Cell โ€ฆSee details»

AIM Biotech - MatTek and AIM Biotech Partner on Advanced 3D โ€ฆ

Boston, MA - June 1, 2023 โ€“ Today, MatTek Life Sciences and AIM Biotech announced a strategic partnership through which the AIM Biotech portfolio will be available for sale through MatTek. Over the last thirty years, MatTek has become the leader in the advanced cell culture space and is continually working to broaden its portfolio of products and services.See details»

AIM Biotech - AIM Biotech Launches High-throughput Organ-on-a โ€ฆ

Boston, MA & Singapore -- November 8, 2021 -- AIM Biotech has launched the idenTx 40 Plate, a high-throughput organ-on-a-chip system that lets researchers at biotechnology and โ€ฆSee details»

Home_AIM Bio

Rabies vaccine combination under development for human use. Such combination covers the globally innovative mRNA rabies vaccine under development, human diploid cell based rabies โ€ฆSee details»

Research Services - AIM Biotech

AIM Biotech Contract Research Services allow you to apply the power of humanized organ-on-a-chip assays to drug development in critical therapeutic areas. Explore further to learn more โ€ฆSee details»

AIM Biotech Launches organiX, a New System to Model Human โ€ฆ

Oct 3, 2022 Boston, Massachusetts and Singapore, Singapore--(Newsfile Corp. - October 3, 2022) - AIM Biotech announced the launch of the organiX System, a lab tool to closely model human disease by adding ...See details»

Developing a new adoptive T cell immunotherapy with AIMโ€™s โ€ฆ

Later, T cells lose the capability of killing tumor cells. Preece and coll discovered that if they used CRISPR to engineer T cells to eliminate PD-1 expression, these T cells could effectively kill โ€ฆSee details»

linkstock.net © 2022. All rights reserved